CStone Pharmaceuticals
HKEX:2616
CStone Pharmaceuticals
HKEX:2616
Price:
3.72
HKD
1.64%
Market Closed
Market Cap:
5.1B
HKD
Section:
Wall Street
Price Targets
Price Target
Average
+24%
Revenue
Forecast
+17%
Operating Income
Forecast
N/A
Net Income
Forecast
N/A
Wall Street
Price Targets
Price Targets Summary
CStone Pharmaceuticals
CStone Pharmaceuticals
Wall Street analysts forecast CStone Pharmaceuticals stock price to drop over the next 12 months.
According to Wall Street analysts, the average 1-year price target for
CStone Pharmaceuticals
is 2.83 HKD
with a low forecast of 2.8 HKD and a high forecast of 2.91 HKD.
Lowest
Price Target
2.8
HKD
25% Downside
Average
Price Target
2.83
HKD
24% Downside
Highest
Price Target
2.91
HKD
22% Downside
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is CStone Pharmaceuticals's stock price target?
Price Target
2.83
HKD
2.83
HKD
According to Wall Street analysts, the average 1-year price target for
CStone Pharmaceuticals
is 2.83 HKD
with a low forecast of 2.8 HKD and a high forecast of 2.91 HKD.
What is CStone Pharmaceuticals's Revenue forecast?
Projected CAGR
25%
25%
The
compound annual growth rate
of CStone Pharmaceuticals's revenue for the next 3 years is
25%.
You don't have any saved screeners yet
